Mainz Biomed N.V (MYNZ) Equity Ratio: 2020-2025
Historic Equity Ratio for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to 0.26.
- Mainz Biomed N.V's Equity Ratio rose 152.56% to 0.26 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.26, marking a year-over-year increase of 152.56%. This contributed to the annual value of 0.46 for FY2024, which is 116.61% up from last year.
- As of Q2 2025, Mainz Biomed N.V's Equity Ratio stood at 0.26, which was down 43.67% from 0.46 recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed N.V's Equity Ratio peaked at 0.86 during Q2 2022, and registered a low of -0.49 during Q2 2024.
- For the 3-year period, Mainz Biomed N.V's Equity Ratio averaged around 0.20, with its median value being 0.26 (2025).
- Per our database at Business Quant, Mainz Biomed N.V's Equity Ratio slumped by 282.54% in 2024 and then soared by 152.56% in 2025.
- Mainz Biomed N.V's Equity Ratio (Quarterly) stood at 0.63 in 2021, then increased by 9.93% to 0.70 in 2022, then crashed by 69.72% to 0.21 in 2023, then surged by 116.61% to 0.46 in 2024, then skyrocketed by 152.56% to 0.26 in 2025.
- Its last three reported values are 0.26 in Q2 2025, 0.46 for Q4 2024, and -0.49 during Q2 2024.